The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival
3 years ago

The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival

Live Mint  

Weeks after Merck & Co. scrapped development of its Covid-19 vaccines in January, one of its senior manufacturing officials began phoning his deputies, telling them their work on a pandemic shot wasn’t actually over. J&J’s unusual collaboration with a rival, and Merck’s speedy manufacturing run-up, reflect one of the biggest challenges of the pandemic: making enough Covid-19 vaccines to meet the high demand. Last December, at the urging of the federal government, the rivals began discussing whether Merck could help make J&J’s Covid-19 vaccine. During a Jan. 4 call between U.S. officials, Dr. Stoffels and then-Merck Chief Executive Ken Frazier, the companies agreed to assess whether Merck’s plants could adapt to make J&J’s shot, the people said. Despite the available rooms and equipment, Merck needed to upgrade its facilities, because J&J’s vaccine uses vials smaller than Merck’s failed Covid-19 shots, as well as a newer vaccine technology.

Manufacturing Workers Production Vaccines West Point Mcgrath Doses Shots Vials Vaccine Merck  manufacturing  workers  shots  big  doses  vials  vaccines  pivot  production  jj  covid19  vaccine  merck  makes  rival  falters

History of this topic

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
6 months, 2 weeks ago

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines

Associated Press  

WASHINGTON — Government advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of the ever-evolving coronavirus called JN.1. But just a few months later, numerous offshoots of JN.1 already are on the rise, prompting Moderna and Pfizer to also test a slightly different vaccine formula targeting …

J&J COVID vaccine factory forced to trash even more doses
2 years, 4 months ago

J&J COVID vaccine factory forced to trash even more doses

Associated Press  

WASHINGTON — About 135 million more doses of Johnson & Johnson’s COVID-19 vaccine from a troubled Baltimore factory will have to be destroyed due to quality problems, Congressional panel leaders said Thursday. The announcement follows a report in May that detailed how more than 400 million vaccine doses made at an Emergent BioSolutions plant had to be trashed. Johnson & …

Africa's COVID vaccine production line in jeopardy
2 years, 7 months ago

Africa's COVID vaccine production line in jeopardy

The Hindu  

Trisha shakes her head when asked if she's vaccinated. 'A massive setback for Africa's plans' In the absence of orders or commitments, Aspen is considering the repurposing of two COVID-19 production lines for the manufacture of other products. "The continent would lose its only existing COVID vaccine manufacturing capacity," Nicolaou says. Africa's major public health body, the Africa Centers for …

J&J Covid-19 vaccine ‘limited’ to some people after clot concerns: Report
2 years, 7 months ago

J&J Covid-19 vaccine ‘limited’ to some people after clot concerns: Report

Hindustan Times  

Johnson & Johnson’s Covid-19 vaccine was limited to use only in adults for whom other shots aren’t appropriate after an investigation of rare and potentially deadly clotting disorder that occurs in some recipients. J&J’s single-shot vaccine has been noted for its convenience compared to two-shot vaccines, especially in remote areas and in populations like the homeless who may be difficult …

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk
2 years, 7 months ago

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk

LA Times  

Vials of the Johnson & Johnson COVID-19 vaccine are seen at a pharmacy in 2021. U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. FDA officials said in a statement that they decided to restrict J&J’s vaccine after taking another look at data on …

Over-50s set to be offered Covid booster vaccines this autumn
2 years, 10 months ago

Over-50s set to be offered Covid booster vaccines this autumn

The Telegraph  

Millions of over-50s could be offered Covid boosters this autumn, as Boris Johnson hailed Britain's vaccine rollout as key to "restoring our liberties in full". Fourth jabs will start being offered to those aged 75 and over from next month, with a further rollout of vaccines expected later this year, when the programme may be much more widely extended. Announcing …

US health experts recommend Pfizer, Moderna COVID-19 shots over J&J vaccine
3 years ago

US health experts recommend Pfizer, Moderna COVID-19 shots over J&J vaccine

Firstpost  

The panel cited the risk of rare but sometimes fatal cases of blood clotting as well as a lower level of effectiveness against COVID-19 in the Johnson & Johnson shot Washington: Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, United States health officials …

UK scientists trial first needle-free air-powered COVID-19 vaccine
3 years ago

UK scientists trial first needle-free air-powered COVID-19 vaccine

Live Mint  

Scientists at the University of Cambridge on Tuesday began a clinical trial of a needle-free air-powered vaccine, which is expected to help combat future variants of COVID-19. "It’s vital that we continue to develop new generation vaccine candidates ready to help keep us safe from the next virus threats. Immunisation arms our immune system to look out for and block …

Why COVID-19 booster shots weren’t tweaked to better match Delta variant
3 years, 2 months ago

Why COVID-19 booster shots weren’t tweaked to better match Delta variant

LA Times  

Vials of the COVID-19 vaccines made by Moderna and Pfizer at a temporary clinic in Exeter, N.H. More COVID-19 booster shots may be on the way — but when it’s your turn, you’ll get an extra dose of the original vaccine formulation, not one updated to better match the extra-contagious Delta variant. The simple answer: The FDA last month OK’d …

FDA panel endorses booster shot for J&J COVID-19 vaccine
3 years, 2 months ago

FDA panel endorses booster shot for J&J COVID-19 vaccine

The Hindu  

U.S. health advisors endorsed a booster of Johnson & Johnson’s COVID-19 vaccine on Friday, citing concern that Americans who got the single-dose shot aren’t as protected as those given two-dose brands. Unable to settle the best timing, the FDA’s advisory panel voted unanimously that the booster should be offered at least two months after people got their earlier shot. “It …

US coronavirus: With more Covid-19 booster shots on the horizon, one expert says mixing and matching doses may be an effective approach
3 years, 2 months ago

US coronavirus: With more Covid-19 booster shots on the horizon, one expert says mixing and matching doses may be an effective approach

CNN  

CNN — Amid the growing prospect of more Covid-19 booster shots becoming available, an expert has suggested that some people could receive a dose of a different vaccine from the one they initially received. “I hope that when the FDA and CDC review data around Moderna and Johnson & Johnson that they will allow a mix-and-match approach,” CNN medical analyst …

Merck says its experimental pill cuts COVID-19 hospitalizations and deaths by half
3 years, 2 months ago

Merck says its experimental pill cuts COVID-19 hospitalizations and deaths by half

LA Times  

Drugmaker Merck says its experimental COVID-19 pill reduced hospitalizations and deaths by half in newly infected people. Drugmaker Merck said Friday that its experimental antiviral pill cuts rates of severe disease and death in half for newly diagnosed COVID-19 patients at high risk of becoming seriously ill. Health experts from Dr. Anthony Fauci on down have long called for a …

J&J Says Booster Shot Increases Protection to 94% for Moderate-Severe Covid-19
3 years, 3 months ago

J&J Says Booster Shot Increases Protection to 94% for Moderate-Severe Covid-19

News 18  

Johnson & Johnson said Tuesday a second shot of its COVID-19 vaccine given about two months after the first increased its effectiveness to 94% in the United States against moderate to severe forms of the disease. President Joe Biden is pushing for booster shots in the face of surging hospitalizations caused by the Delta variant and J&J, the only drugmaker …

Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds
3 years, 3 months ago

Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds

CNN  

CNN — A two-dose version of Johnson & Johnson’s coronavirus vaccine provides 94% protection against symptomatic infection, the company said Tuesday – making a two-dose regimen of J&J’s Janssen vaccine comparable to a two-dose regimen of Moderna’s or Pfizer’s. “Our large real-world-evidence and Phase 3 studies confirm that the single-shot Johnson & Johnson vaccine provides strong and long-lasting protection against …

Made by Biological E, J&J's Single-Shot Covid Vaccine to Hit Market Next Month
3 years, 3 months ago

Made by Biological E, J&J's Single-Shot Covid Vaccine to Hit Market Next Month

News 18  

US Pharma giant Johnson & Johnson’s single shot vaccine manufactured by Hyderabad-based Biological E is likely to be rolled out by October, News18.com has learnt. The vaccine batches are expected to go for the final testing at the apex laboratories — Central Drugs Laboratory, Kasauli and National Centre for Cell Science, Pune — by next week. “The vaccine is likely …

US health officials call for booster shots against COVID-19
3 years, 4 months ago

US health officials call for booster shots against COVID-19

Associated Press  

WASHINGTON — U.S. health officials Wednesday announced plans to dispense COVID-19 booster shots to all Americans to shore up their protection amid the surging delta variant and signs that the vaccines’ effectiveness is slipping. Dr. Anthony Fauci, the government’s foremost expert on COVID-19, said one of the key lessons of the coronavirus is that it’s better to “stay ahead of …

Johnson & Johnson says talks with India on Covid vaccine Janssen still going on
3 years, 4 months ago

Johnson & Johnson says talks with India on Covid vaccine Janssen still going on

Hindustan Times  

Days after India's drugs regulator announced that Johnson & Johnson has pulled out its proposal seeking accelerated approval of its Covid-19 vaccine, the company said that the talks are still on. A health worker prepares a dose of Janssen Johnson & Johnson Covid-19 vaccine at Leopold Sedar Senghor stadium in Dakar, Senegal. Without giving any details, Central Drugs Standard Control …

Johnson & Johnson Withdraws Proposal for Speedy Covid Vaccine Approval in India
3 years, 4 months ago

Johnson & Johnson Withdraws Proposal for Speedy Covid Vaccine Approval in India

News 18  

The Central Drugs Standard Control Organisation said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details. The drugmaker's withdrawal comes as India tackles legal challenges with manufacturers over indemnity issues, with its junior health minister saying last week that a team had been formed to engage …

What is a Covid-19 vaccine 'breakthrough' case?
3 years, 4 months ago

What is a Covid-19 vaccine 'breakthrough' case?

India Today  

What is a Covid-19 vaccine “breakthrough” case? If you do end up getting sick despite vaccination, experts say the shots help reduce the severity of the illness — the main reason to get vaccinated. Previously, health officials believed vaccinated people who get breakthrough infections were unlikely to spread the virus. But with the more contagious delta variant that is now …

FDA is letting troubled COVID vaccine factory restart, company says
3 years, 4 months ago

FDA is letting troubled COVID vaccine factory restart, company says

LA Times  

A vial of Johnson & Johnson’s COVID-19 vaccine is used at a pop-up clinic in the Staten Island. The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine, the company said Thursday. The lapses at the Bayview factory have hampered J&J’s efforts to be a major player in …

FDA adds warning of rare reaction risk to J&J Covid vaccine
3 years, 5 months ago

FDA adds warning of rare reaction risk to J&J Covid vaccine

India TV News  

US regulators on Monday added a new warning to Johnson & Johnson's COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction, but said it's not entirely clear the shot caused the problem. Health officials described the side effect as a “small possible risk" for those getting the shot.\ The action comes after the FDA and the Centers …

Dangerous trend: WHO warns against mixing and matching Covid vaccines
3 years, 5 months ago

Dangerous trend: WHO warns against mixing and matching Covid vaccines

India Today  

The World Health Organisation's chief scientist on Monday advised against people mixing and matching Covid-19 vaccines from different manufacturers, calling it a "dangerous trend" since there was little data available about the health impact. Infectious disease experts are weighing whether people who received Johnson & Johnson's single-dose vaccine should receive a booster of the Pfizer or Moderna mRNA-based vaccine which …

Johnson & Johnson\'s single-dose vaccine shows promising signs against Delta variant
3 years, 5 months ago

Johnson & Johnson\'s single-dose vaccine shows promising signs against Delta variant

Deccan Chronicle  

New Jersey: Johnson & Johnson on Thursday announced that its single-shot COVID-19 vaccine showed promising signs of protection against the Delta variant rapidly spreading across the US and other countries, in a small laboratory study. "Today's newly announced studies reinforce the ability of the Johnson & Johnson COVID-19 vaccine to help protect the health of people globally," said Paul Stoffels, …

Johnson & Johnson's COVID Vaccine Is Effective Against The Delta Variant, Studies Find
3 years, 5 months ago

Johnson & Johnson's COVID Vaccine Is Effective Against The Delta Variant, Studies Find

NPR  

Johnson & Johnson's COVID Vaccine Is Effective Against The Delta Variant, Studies Find Enlarge this image toggle caption David Zalubowski/AP David Zalubowski/AP Johnson & Johnson's COVID-19 vaccine offers strong protection against the delta variant of the coronavirus, the company said Thursday. In one small laboratory study, researchers observed what happened to the blood of eight vaccinated individuals when it was …

Biden promotes milestone of 300M vaccine shots in 150 days
3 years, 6 months ago

Biden promotes milestone of 300M vaccine shots in 150 days

India Today  

President Joe Biden took a cautious victory lap Friday in his quest to bring the Covid-19 pandemic under control, announcing that 300 million vaccine shots have been administered in the 150 days since he took office. Prayerfully, a summer of joy.” But as Biden marks one milestone, he is in danger of failing to meet another: his target to have …

Boris Johnson extends England’s pandemic restrictions amid variant concerns
3 years, 6 months ago

Boris Johnson extends England’s pandemic restrictions amid variant concerns

CNN  

London CNN — England’s plan to lift all Covid-19 restrictions on June 21 has been scuppered by the Delta variant of the virus, Boris Johnson said Monday. Despite the UK’s successful vaccine rollout, which has given two doses to more than half of the adult population, the prevalence of the Delta variant – first identified in India – has convinced …

Johnson & Johnson's vaccine drive stalls out in U.S after safety pause
3 years, 6 months ago

Johnson & Johnson's vaccine drive stalls out in U.S after safety pause

India Today  

Safety concerns about Johnson & Johnson's COVID-19 vaccine along with overall flagging demand for vaccinations have slowed its U.S. rollout to a crawl, leaving close to half of the 21 million doses produced for the United States sitting unused. J&J is working with the U.S. government and health authorities to support use of its vaccine, the spokesperson said in a …

Johnson and Johnson Joins Hand with Telangana-based Biological E to Manufacture Covid Vaccine
3 years, 7 months ago

Johnson and Johnson Joins Hand with Telangana-based Biological E to Manufacture Covid Vaccine

News 18  

US pharmaceutical company Johnson and Johnson has joined hands with Telangana-based Biological E Limited for the manufacturing of the COVID-19 vaccine. We believe Biological E. will be an important part of our global COVID-19 vaccine supply network, where multiple manufacturing sites are involved in the production of our vaccine across different facilities, sometimes in different countries and continents, before the …

J&J vaccine: Risk of dying from Covid-19 40 times the risk of rare blood clot after receiving vaccine
3 years, 7 months ago

J&J vaccine: Risk of dying from Covid-19 40 times the risk of rare blood clot after receiving vaccine

CNN  

CNN — The risk of dying from Covid-19 is 40 times the risk of developing a rare blood clotting condition after getting the Johnson & Johnson vaccine, a CNN analysis shows. The US Centers for Disease Control and Prevention said Wednesday it has received reports of 28 people who have developed a rare blood clotting syndrome out of 8.7 million …

Johnson & Johnson vaccine shipments to California resume as COVID cases keep falling
3 years, 7 months ago

Johnson & Johnson vaccine shipments to California resume as COVID cases keep falling

LA Times  

A box of the Johnson & Johnson COVID-19 vaccine at Kedren Health in Los Angeles on April 15. California is poised to receive almost 90,000 doses of the Johnson & Johnson vaccine next week as U.S. officials resume supplies of the single-shot COVID-19 vaccine. “We have a vaccine safety program that’s really 100% transparent so that people can understand that, …

Blood clots and Johnson & Johnson vaccine: What you need to know
3 years, 7 months ago

Blood clots and Johnson & Johnson vaccine: What you need to know

CNN  

CNN — Have you recently had the single-shot Johnson & Johnson Covid-19 vaccine? The six women developed symptoms of this “rare and severe type of blood clot” between six and 13 days after their J&J vaccination, the CDC said. “Reports of adverse events following the use of J&J/Janssen vaccine suggest an increased risk of a rare adverse event called thrombosis …

California’s COVID-19 vaccination pace slowed after Johnson & Johnson pause, data show
3 years, 7 months ago

California’s COVID-19 vaccination pace slowed after Johnson & Johnson pause, data show

LA Times  

California’s COVID-19 inoculation pace tailed off after officials paused use of the Johnson & Johnson vaccine as a precaution earlier this month, according to data compiled by The Times. “To end this pandemic, we need to use every dose we have — and the Johnson & Johnson vaccine is a critical piece of that strategy,” Mayor Eric Garcetti said in …

Blood clots and Johnson & Johnson vaccine: What you need to know
3 years, 7 months ago

Blood clots and Johnson & Johnson vaccine: What you need to know

CNN  

CNN — Have you recently had the single-shot Johnson & Johnson Covid-19 vaccine? The six women developed symptoms of this “rare and severe type of blood clot” between six and 13 days after their J&J vaccination, the CDC said. “Reports of adverse events following the use of J&J/Janssen vaccine suggest an increased risk of a rare adverse event called thrombosis …

US to resume Johnson & Johnson COVID-19 vaccinations despite rare risk of blood clots
3 years, 8 months ago

US to resume Johnson & Johnson COVID-19 vaccinations despite rare risk of blood clots

Firstpost  

Washington: US health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson’s single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot. CDC Director Dr. Rochelle Walensky added that the pause should increase confidence in vaccine safety, showing “that we are taking every one of those needles in a haystack …

US to resume J&J COVID vaccinations despite rare clot risk
3 years, 8 months ago

US to resume J&J COVID vaccinations despite rare clot risk

Associated Press  

U.S. health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson’s single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot. CDC Director Dr. Rochelle Walensky added that the pause should increase confidence in vaccine safety, showing “that we are taking every one of those needles in a haystack that …

April 23, 2021, Covid-19 vaccine and world news
3 years, 8 months ago

April 23, 2021, Covid-19 vaccine and world news

CNN  

In this March 3 photo, a pharmacist holds a vial of the Johnson & Johnson Covid-19 vaccine at a hospital in Bay Shore, New York. AP Photo/Mark Lennihan A subcommittee of vaccine advisers to US Centers for Disease Control and Prevention will recommend Friday that the Johnson & Johnson Covid-19 vaccine continue to be used in the United States, an …

April 23, 2021, Covid-19 vaccine and world news
3 years, 8 months ago

April 23, 2021, Covid-19 vaccine and world news

CNN  

In this March 3 photo, a pharmacist holds a vial of the Johnson & Johnson Covid-19 vaccine at a hospital in Bay Shore, New York. AP Photo/Mark Lennihan A subcommittee of vaccine advisers to US Centers for Disease Control and Prevention will recommend Friday that the Johnson & Johnson Covid-19 vaccine continue to be used in the United States, an …

FDA inspection found problems at factory making J&J vaccine
3 years, 8 months ago

FDA inspection found problems at factory making J&J vaccine

Associated Press  

The Baltimore factory hired to help make Johnson & Johnson’s COVID-19 vaccine was dirty, didn’t follow proper manufacturing procedures and had poorly trained staff, resulting in contamination of material going into a batch of shots, U.S. regulators said Wednesday. Agency inspectors said a batch of bulk drug substance for J&J’s single-shot vaccine was contaminated with material used to make COVID-19 …

EU regulator finds possible link between Johnson & Johnson vaccine and blood clots, but says benefits outweigh risks
3 years, 8 months ago

EU regulator finds possible link between Johnson & Johnson vaccine and blood clots, but says benefits outweigh risks

CNN  

London CNN — Europe’s medicines regulator said it has found a possible link between the Johnson & Johnson Covid-19 vaccine and rare blood clots, but emphasized that the overall benefits of getting the shot outweigh the risks. The European Medicines Agency concluded that “a warning about unusual blood clots with low blood platelets should be added to the product information” …

EU regulator finds possible link between Johnson & Johnson COVID shot, blood clots
3 years, 8 months ago

EU regulator finds possible link between Johnson & Johnson COVID shot, blood clots

LA Times  

Experts at the agency that regulates drugs for the European Union said Tuesday that they found a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare blood clots after a small number of cases were reported in the U.S., but they confirmed that the vaccine’s benefits still outweighed the very small risks of recipients developing the unusual …

EU regulator finds J&J vaccine has ‘possible link’ to blood clots
3 years, 8 months ago

EU regulator finds J&J vaccine has ‘possible link’ to blood clots

Al Jazeera  

The European Union’s medicines regulator on Tuesday said it had found a “possible link” between Johnson & Johnson’s COVID-19 vaccine and the development of rare blood clots in a small number of recipients, but concluded the shot’s overall benefits outweigh any risks associated with its use. The European Medicines Agency said its safety committee decided that a warning about unusual …

EU Regulator: 'Possible Link' Between Johnson & Johnson Vaccine And Rare Blood Clots
3 years, 8 months ago

EU Regulator: 'Possible Link' Between Johnson & Johnson Vaccine And Rare Blood Clots

NPR  

EU Regulator: 'Possible Link' Between Johnson & Johnson Vaccine And Rare Blood Clots Enlarge this image toggle caption Allen J. Schaben/Los Angeles Times via Getty Images Allen J. Schaben/Los Angeles Times via Getty Images The European Union's drug regulator said Tuesday it had concluded there is a "possible link" between the Johnson & Johnson COVID-19 vaccine and several cases in …

Health officials considered issuing a warning before deciding to recommend a pause of the Johnson &Johnson Covid-19 vaccine
3 years, 8 months ago

Health officials considered issuing a warning before deciding to recommend a pause of the Johnson &Johnson Covid-19 vaccine

CNN  

CNN — As health officials discussed how to handle reports of blood clots possibly linked to Johnson & Johnson’s Covid-19 vaccine, one option considered was issuing a warning to health care providers without recommending a full pause, multiple sources told CNN. The CDC and FDA last week recommended that the United States pause the use of Johnson & Johnson’s Covid-19 …

Johnson & Johnson said blood clots have been reported with all Covid-19 vaccines. The author of the study they cited says they’re wrong.
3 years, 8 months ago

Johnson & Johnson said blood clots have been reported with all Covid-19 vaccines. The author of the study they cited says they’re wrong.

CNN  

CNN — When news broke that Johnson & Johnson’s Covid-19 vaccine might be linked to blood clots, the company responded by pointing a finger at Pfizer and Moderna’s vaccines, issuing a media statement that said a study showed there were reports of blood clots with their vaccines as well. “We didn’t find anyone with blood clots,” Dr. Eun-Ju Lee, an …

Fauci predicts J&J vaccine to come back to market with restrictions or warnings by Friday
3 years, 8 months ago

Fauci predicts J&J vaccine to come back to market with restrictions or warnings by Friday

CNN  

CNN — Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said Sunday that he expects a decision to be made about the Johnson & Johnson Covid-19 vaccine by Friday, predicting the vaccine would come back on the market with restrictions or warnings. “I don’t want to get ahead of the CDC and the FDA and …

U.S. pause on Johnson & Johnson vaccine could be felt the most in poor countries
3 years, 8 months ago

U.S. pause on Johnson & Johnson vaccine could be felt the most in poor countries

LA Times  

More than a billion people around the world have been waiting for the Johnson & Johnson vaccine — a cheap, easy-to-transport, one-dose injection that reduces the risk from COVID-19. The U.S. Food and Drug Administration, which this week recommended that use of the vaccine be paused while scientists study a possible link to extremely rare blood clots, has no authority …

Pfizer and Moderna DECLINED joining Johnson & Johnson study of vaccine blood clot risks
3 years, 8 months ago

Pfizer and Moderna DECLINED joining Johnson & Johnson study of vaccine blood clot risks

Daily Mail  

Johnson & Johnson privately reached out to rival COVID-19 vaccine makers to join in an effort to study the risks of blood clots. It comes as a pause of J&J's vaccine continues in the U.S. after multiple people developed rare, but serious, blood clots within days of receiving the shot. Johnson & Johnson privately asked other vaccine manufacturers to join …

Johnson & Johnson sought help from vaccine rivals after blood clot concerns emerged with its own immunizations
3 years, 8 months ago

Johnson & Johnson sought help from vaccine rivals after blood clot concerns emerged with its own immunizations

CNN  

New York CNN — Johnson & Johnson sought help from its three rival Covid-19 vaccine makers to look into reports of blood clots, but Pfizer and Moderna both declined, the Wall Street Journal reported on Friday, citing people familiar with the situation. Johnson & Johnson told CNN in an email that “the safety of the patients who use our products …

The dilemma in pausing J&J vaccine over risk of blood clots: Will it save lives or cost them?
3 years, 8 months ago

The dilemma in pausing J&J vaccine over risk of blood clots: Will it save lives or cost them?

LA Times  

“Do no harm.” The phrase, from the Hippocratic oath, is the guiding principle of medical care. “I would characterize it as wrenching,” Vanderbilt University vaccine expert Dr. William Schaffner said of the meeting, which he attended as a nonvoting representative of the National Foundation for Infectious Diseases. In addition, many men with unusual blood clots have shown up in Europe …

Discover Related